West Pharmaceutical Services, Inc. (WST)
USD 216.13
(0.46%)
USD 216.13
(0.46%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.94 Billion USD | 2.18% |
| 2022 | 2.88 Billion USD | 1.95% |
| 2021 | 2.83 Billion USD | 31.89% |
| 2020 | 2.14 Billion USD | 16.69% |
| 2019 | 1.83 Billion USD | 7.13% |
| 2018 | 1.71 Billion USD | 7.4% |
| 2017 | 1.59 Billion USD | 5.96% |
| 2016 | 1.5 Billion USD | 7.81% |
| 2015 | 1.39 Billion USD | -1.52% |
| 2014 | 1.42 Billion USD | 3.87% |
| 2013 | 1.36 Billion USD | 8.05% |
| 2012 | 1.26 Billion USD | 6.21% |
| 2011 | 1.19 Billion USD | 7.93% |
| 2010 | 1.1 Billion USD | 4.64% |
| 2009 | 1.05 Billion USD | 0.44% |
| 2008 | 1.05 Billion USD | 3.04% |
| 2007 | 1.02 Billion USD | 11.69% |
| 2006 | 913.3 Million USD | 30.53% |
| 2005 | 699.7 Million USD | 29.19% |
| 2004 | 541.6 Million USD | 10.37% |
| 2003 | 490.7 Million USD | 16.92% |
| 2002 | 419.7 Million USD | 5.74% |
| 2001 | 396.9 Million USD | -7.72% |
| 2000 | 430.1 Million USD | -8.31% |
| 1999 | 469.1 Million USD | 4.31% |
| 1998 | 449.7 Million USD | -0.62% |
| 1997 | 452.5 Million USD | -1.37% |
| 1996 | 458.8 Million USD | 11.12% |
| 1995 | 412.9 Million USD | 13.09% |
| 1994 | 365.1 Million USD | 4.7% |
| 1993 | 348.7 Million USD | 3.1% |
| 1992 | 338.2 Million USD | 2.61% |
| 1991 | 329.6 Million USD | 1.98% |
| 1990 | 323.2 Million USD | 4.7% |
| 1989 | 308.7 Million USD | 7.11% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 702 Million USD | 0.95% |
| 2024 Q3 | 746.9 Million USD | 6.4% |
| 2024 Q1 | 695.4 Million USD | -5.0% |
| 2023 Q2 | 753.8 Million USD | 5.19% |
| 2023 Q1 | 716.6 Million USD | 1.11% |
| 2023 FY | 2.94 Billion USD | 2.18% |
| 2023 Q3 | 747.4 Million USD | -0.85% |
| 2023 Q4 | 732 Million USD | -2.06% |
| 2022 Q2 | 771.3 Million USD | 7.13% |
| 2022 FY | 2.88 Billion USD | 1.95% |
| 2022 Q1 | 720 Million USD | -1.48% |
| 2022 Q4 | 708.7 Million USD | 3.17% |
| 2022 Q3 | 686.9 Million USD | -10.94% |
| 2021 Q4 | 730.8 Million USD | 3.44% |
| 2021 FY | 2.83 Billion USD | 31.89% |
| 2021 Q1 | 670.7 Million USD | 15.6% |
| 2021 Q2 | 723.6 Million USD | 7.89% |
| 2021 Q3 | 706.5 Million USD | -2.36% |
| 2020 FY | 2.14 Billion USD | 16.69% |
| 2020 Q2 | 527.2 Million USD | 7.26% |
| 2020 Q1 | 491.5 Million USD | 4.44% |
| 2020 Q3 | 548 Million USD | 3.95% |
| 2020 Q4 | 580.2 Million USD | 5.88% |
| 2019 Q2 | 469.7 Million USD | 5.91% |
| 2019 Q1 | 443.5 Million USD | 4.97% |
| 2019 Q3 | 456.1 Million USD | -2.9% |
| 2019 Q4 | 470.6 Million USD | 3.18% |
| 2019 FY | 1.83 Billion USD | 7.13% |
| 2018 Q4 | 422.5 Million USD | -2.13% |
| 2018 Q1 | 415.7 Million USD | 0.02% |
| 2018 Q2 | 447.5 Million USD | 7.65% |
| 2018 Q3 | 431.7 Million USD | -3.53% |
| 2018 FY | 1.71 Billion USD | 7.4% |
| 2017 Q2 | 397.6 Million USD | 2.55% |
| 2017 Q1 | 387.7 Million USD | 1.41% |
| 2017 Q3 | 398.2 Million USD | 0.15% |
| 2017 Q4 | 415.6 Million USD | 4.37% |
| 2017 FY | 1.59 Billion USD | 5.96% |
| 2016 Q2 | 388 Million USD | 7.15% |
| 2016 FY | 1.5 Billion USD | 7.81% |
| 2016 Q3 | 376.7 Million USD | -2.91% |
| 2016 Q1 | 362.1 Million USD | 0.67% |
| 2016 Q4 | 382.3 Million USD | 1.49% |
| 2015 Q1 | 335.9 Million USD | -3.97% |
| 2015 FY | 1.39 Billion USD | -1.52% |
| 2015 Q2 | 359.7 Million USD | 7.09% |
| 2015 Q3 | 344.5 Million USD | -4.23% |
| 2015 Q4 | 359.7 Million USD | 4.41% |
| 2014 Q3 | 355.9 Million USD | -3.52% |
| 2014 FY | 1.42 Billion USD | 3.87% |
| 2014 Q1 | 346.8 Million USD | 1.2% |
| 2014 Q2 | 368.9 Million USD | 6.37% |
| 2014 Q4 | 349.8 Million USD | -1.71% |
| 2013 Q3 | 341.8 Million USD | -0.78% |
| 2013 FY | 1.36 Billion USD | 8.05% |
| 2013 Q4 | 342.7 Million USD | 0.26% |
| 2013 Q2 | 344.5 Million USD | 1.5% |
| 2013 Q1 | 339.4 Million USD | 5.57% |
| 2012 Q1 | 316.3 Million USD | 7.08% |
| 2012 FY | 1.26 Billion USD | 6.21% |
| 2012 Q2 | 324.8 Million USD | 2.69% |
| 2012 Q4 | 321.5 Million USD | 5.83% |
| 2012 Q3 | 303.8 Million USD | -6.47% |
| 2011 FY | 1.19 Billion USD | 7.93% |
| 2011 Q1 | 295.4 Million USD | 6.72% |
| 2011 Q2 | 307.9 Million USD | 4.23% |
| 2011 Q3 | 293.6 Million USD | -4.64% |
| 2011 Q4 | 295.4 Million USD | 0.61% |
| 2010 Q1 | 274.7 Million USD | -6.37% |
| 2010 FY | 1.1 Billion USD | 4.64% |
| 2010 Q4 | 276.8 Million USD | 1.99% |
| 2010 Q3 | 271.4 Million USD | -3.69% |
| 2010 Q2 | 281.8 Million USD | 2.58% |
| 2009 Q3 | 258.9 Million USD | -0.8% |
| 2009 Q4 | 293.4 Million USD | 13.33% |
| 2009 FY | 1.05 Billion USD | 0.44% |
| 2009 Q2 | 261 Million USD | 7.67% |
| 2009 Q1 | 242.4 Million USD | -0.98% |
| 2008 Q3 | 256.2 Million USD | -8.27% |
| 2008 Q4 | 244.8 Million USD | -4.45% |
| 2008 Q1 | 270.7 Million USD | 5.7% |
| 2008 FY | 1.05 Billion USD | 3.04% |
| 2008 Q2 | 279.3 Million USD | 3.18% |
| 2007 Q2 | 263.7 Million USD | 2.37% |
| 2007 Q4 | 256.1 Million USD | 5.52% |
| 2007 Q1 | 257.6 Million USD | 11.08% |
| 2007 FY | 1.02 Billion USD | 11.69% |
| 2007 Q3 | 242.7 Million USD | -7.96% |
| 2006 Q4 | 231.9 Million USD | 6.18% |
| 2006 Q1 | 222.8 Million USD | 13.85% |
| 2006 FY | 913.3 Million USD | 30.53% |
| 2006 Q2 | 240.2 Million USD | 7.81% |
| 2006 Q3 | 218.4 Million USD | -9.08% |
| 2005 Q3 | 181.6 Million USD | 4.97% |
| 2005 FY | 699.7 Million USD | 29.19% |
| 2005 Q4 | 195.7 Million USD | 7.76% |
| 2005 Q2 | 173 Million USD | 15.72% |
| 2005 Q1 | 149.5 Million USD | 11.07% |
| 2004 Q3 | 135.3 Million USD | -2.03% |
| 2004 FY | 541.6 Million USD | 10.37% |
| 2004 Q2 | 138.1 Million USD | 3.37% |
| 2004 Q4 | 134.6 Million USD | -0.52% |
| 2004 Q1 | 133.6 Million USD | 5.7% |
| 2003 Q3 | 120.1 Million USD | -4.98% |
| 2003 FY | 490.7 Million USD | 16.92% |
| 2003 Q2 | 126.4 Million USD | 7.3% |
| 2003 Q1 | 117.8 Million USD | 13.93% |
| 2003 Q4 | 126.4 Million USD | 5.25% |
| 2002 Q3 | 104.9 Million USD | -2.6% |
| 2002 FY | 419.7 Million USD | 5.74% |
| 2002 Q1 | 103.7 Million USD | 104.94% |
| 2002 Q2 | 107.7 Million USD | 3.86% |
| 2002 Q4 | 103.4 Million USD | -1.43% |
| 2001 Q3 | 112.9 Million USD | -3.67% |
| 2001 Q4 | 50.6 Million USD | -55.18% |
| 2001 Q1 | 116.2 Million USD | 10.46% |
| 2001 Q2 | 117.2 Million USD | 0.86% |
| 2001 FY | 396.9 Million USD | -7.72% |
| 2000 Q3 | 104.5 Million USD | -7.28% |
| 2000 Q1 | 107.7 Million USD | -6.67% |
| 2000 FY | 430.1 Million USD | -8.31% |
| 2000 Q2 | 112.7 Million USD | 4.64% |
| 2000 Q4 | 105.2 Million USD | 0.67% |
| 1999 Q4 | 115.4 Million USD | 0.26% |
| 1999 Q1 | 114.2 Million USD | -0.52% |
| 1999 Q2 | 124.4 Million USD | 8.93% |
| 1999 Q3 | 115.1 Million USD | -7.48% |
| 1999 FY | 469.1 Million USD | 4.31% |
| 1998 Q4 | 114.8 Million USD | 0.79% |
| 1998 Q3 | 113.9 Million USD | -1.64% |
| 1998 FY | 449.7 Million USD | -0.62% |
| 1998 Q1 | 105.2 Million USD | -3.93% |
| 1998 Q2 | 115.8 Million USD | 10.08% |
| 1997 Q3 | 105.2 Million USD | -14.54% |
| 1997 FY | 452.5 Million USD | -1.37% |
| 1997 Q1 | 114.7 Million USD | 0.09% |
| 1997 Q2 | 123.1 Million USD | 7.32% |
| 1997 Q4 | 109.5 Million USD | 4.09% |
| 1996 Q1 | 113.9 Million USD | 5.86% |
| 1996 Q3 | 111.3 Million USD | -6.47% |
| 1996 Q4 | 114.6 Million USD | 2.96% |
| 1996 FY | 458.8 Million USD | 11.12% |
| 1996 Q2 | 119 Million USD | 4.48% |
| 1995 Q3 | 101.1 Million USD | -7.25% |
| 1995 Q1 | 95.2 Million USD | -3.94% |
| 1995 Q2 | 109 Million USD | 14.5% |
| 1995 Q4 | 107.6 Million USD | 6.43% |
| 1995 FY | 412.9 Million USD | 13.09% |
| 1994 Q3 | 87.4 Million USD | -4.48% |
| 1994 Q4 | 99.1 Million USD | 13.39% |
| 1994 FY | 365.1 Million USD | 4.7% |
| 1994 Q1 | 87.1 Million USD | -6.14% |
| 1994 Q2 | 91.5 Million USD | 5.05% |
| 1993 FY | 348.7 Million USD | 3.1% |
| 1993 Q1 | 86.9 Million USD | -1.7% |
| 1993 Q2 | 87.1 Million USD | 0.23% |
| 1993 Q3 | 81.9 Million USD | -5.97% |
| 1993 Q4 | 92.8 Million USD | 13.31% |
| 1992 FY | 338.2 Million USD | 2.61% |
| 1992 Q4 | 88.4 Million USD | 8.73% |
| 1992 Q3 | 81.3 Million USD | -6.23% |
| 1992 Q2 | 86.7 Million USD | 5.99% |
| 1992 Q1 | 81.8 Million USD | -0.49% |
| 1991 Q3 | 79.6 Million USD | -2.69% |
| 1991 Q2 | 81.8 Million USD | -4.99% |
| 1991 Q1 | 86.1 Million USD | 7.09% |
| 1991 FY | 329.6 Million USD | 1.98% |
| 1991 Q4 | 82.2 Million USD | 3.27% |
| 1990 Q4 | 80.4 Million USD | 4.55% |
| 1990 Q1 | 83.8 Million USD | 5.14% |
| 1990 FY | 323.2 Million USD | 4.7% |
| 1990 Q3 | 76.9 Million USD | -6.33% |
| 1990 Q2 | 82.1 Million USD | -2.03% |
| 1989 FY | 308.7 Million USD | 7.11% |
| 1989 Q2 | 79.5 Million USD | -0.75% |
| 1989 Q1 | 80.1 Million USD | 6.23% |
| 1989 Q3 | 69.4 Million USD | -12.7% |
| 1989 Q4 | 79.7 Million USD | 14.84% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Alcon Inc. | 10.09 Billion USD | 70.771% |
| AptarGroup, Inc. | 3.48 Billion USD | 15.417% |
| Baxter International Inc. | 14.81 Billion USD | 80.086% |
| Becton, Dickinson and Company | 20.17 Billion USD | 85.381% |
| Bausch + Lomb Corporation | 4.14 Billion USD | 28.852% |
| Haemonetics Corporation | 1.3 Billion USD | -125.338% |
| Envista Holdings Corp | 2.56 Billion USD | -14.935% |
| ResMed Inc. | 4.68 Billion USD | 37.041% |
| Teleflex Incorporated | 2.97 Billion USD | 0.83% |
| Warby Parker Inc. | 669.76 Million USD | -340.423% |